Live Bending Spoons Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about

Dermata Therapeutics, Inc.

DRMA DRMAW

About Dermata Therapeutics, Inc.

Dermata Therapeutics develops innovative topical dermatology products targeting skin diseases like acne, psoriasis, and hyperhidrosis, as well as aesthetic conditions. Utilizing proprietary Spongilla technology derived from natural freshwater sponges, their treatments aim for rapid, effective, and patient-friendly applications. Focused on unmet medical needs, the company collaborates with partners to develop and commercialize minimally invasive, natural-based therapies for medical and aesthetic markets worldwide.

This description was generated via AI from an annual report. Updated about 1 year ago.

Latest SEC Filings from Dermata Therapeutics, Inc.